L&Q Notice: TruScreen Limited Ordinary Shares (“TRU”)

LISTING AND QUOTATION NOTICE: NZX MAIN BOARD
TRUSCREEN LIMITED ORDINARY SHARES (“TRU”)
NZX Limited, Level 1, NZX Centre, 11 Cable Street, PO Box 2959, Wellington 6140, New Zealand
Tel +64 4 472 7599, www.nzx.com


Company:
TruScreen Limited
Issuer Code:
TRU
ISIN:
NZTRUE0001S7
Short Name:
TruScreen
Registered Office:
C/- HLB Mann Judd Limited,
Level 6, Equitable House,
57 Symonds Street,
Grafton,
Auckland
Website:
www.truscreen.com
Telephone Number:
+61 2 9262 4644
Financial Year End:
31 March
Nature of Business:
TruScreen offers the latest technology in cervical screening,
providing real-time, accurate detection of pre-cancerous and
cancerous cervical cells to help improve the health and well-
being of women around the world.
Directors:
Anthony Ho (Chairman), Christopher Horn, Robert Hunter
(William Hunter as his alternate), Kelly (Con) Hickey, Ronald
Jones and Chris Lawrence
Details of Issue:
Migration of the Listing and Quotation of TruScreen Limited
ordinary shares from the NZX Alternative Market to the NZX Main
Board.
Total Securities to be Quoted:
216,857,441 ordinary shares
Auditors:
BDO Auckland
Solicitors:
Jeremy Carr of Burton Partners
Share Registrar:
Link Market Services Limited
Settlement Status:
NZCDC Settlement System
Commencement of Trading on
the NZX Main Board:
17 December 2018


Mark Peterson
Chief Executive Officer
NZX Limited

5 December 2018